DeepMed Research

Radboud University Medical Center

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1951-01-01

Employees: -

Market Cap: -

Website: http://www.radboudumc.nl

Clinical Trials

Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer Metastases

Not Applicable

Active, not recruiting

Conditions: Multi-organ Metastatic Colorectal Cancer

Interventions: Drug: XELOX regimen according to standard procedures
Drug: FOLFOX regimen according to standard procedures
Procedure: Surgery
Procedure: tumor biopsy
Other: radiofrequency ablation (RFA)
Other: transarterial chemo-embolization using irinotecan drug-eluted beads ((DEBIRI-)TACE)
Radiation: stereotactic body radiation therapy (SBRT)
Drug: Bevacizumab

First Posted Date: 2013-02-15

Last Posted Date: 2025-04-15

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 478

Registration Number: NCT01792934

Locations: 🇳🇱
Jeroen Bosch Ziekenhuis, Den Bosch, Netherlands
🇳🇱
Noordwest Ziekenhuis Groep, Alkmaar, Netherlands
🇳🇱
Ziekenhuisgroep Twente, Almelo, Netherlands

and more 26 locations

The Senior Step Study How Elderly Help Themselves Maximally Forward

Not Applicable

Completed

Conditions: Self-management for Mobility Improvement in the Elderly

Interventions: Behavioral: Mobility feedback device with use of instruction book

First Posted Date: 2013-02-15

Last Posted Date: 2018-08-29

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 150

Registration Number: NCT01792180

Locations: 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands

Perioperative Δ9-THC for Postsurgical Pain

Phase 2

Conditions: Pain

Interventions: Drug: Diazepam/placebo
Drug: Namisol

First Posted Date: 2013-02-13

Last Posted Date: 2013-10-23

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 40

Registration Number: NCT01790555

Locations: 🇳🇱
Radboud University Nijmegen Medical Center, Nijmegen, Gelderland, Netherlands

pRophylactic halopEriDol Use for Delirium in iCu patiEnts With a High Risk for Delirium

Phase 4

Completed

Conditions: Delirium

Interventions: Drug: Haloperidol 2 mg/q8h
Drug: Haloperidol 1 mg/q8h
Drug: Placebo

First Posted Date: 2013-02-07

Last Posted Date: 2020-11-12

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 1800

Registration Number: NCT01785290

Locations: 🇳🇱
Radboud University Medical Centre, Nijmegen, Netherlands

Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine or Chloroquine/Azithromycin Prophylaxis

Phase 1

Withdrawn

Conditions: Malaria, Falciparum

Interventions: Drug: Azithromycin capsules
Drug: Placebo
Biological: Immunization with falciparum

First Posted Date: 2013-02-04

Last Posted Date: 2014-11-13

Lead Sponsor: Radboud University Medical Center

Registration Number: NCT01783340

Locations: 🇳🇱
Leiden University Medical Centre, Leiden, Netherlands

Pharmacokinetics of Micafungin in Patients Intensive Care Unit

Completed

Conditions: Invasive Fungal Infection

Interventions: Drug: micafungin

First Posted Date: 2013-02-04

Last Posted Date: 2020-11-30

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 20

Registration Number: NCT01783379

Locations: 🇳🇱
Rijstate Hospital, Arnhem, Netherlands
🇳🇱
Gelderse Vallei Hospital, Ede, Netherlands
🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

and more 1 locations

Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin.

Phase 1

Completed

Conditions: Hypercholesterolaemia
HIV

Interventions: Drug: raltegravir
Drug: Atorvastatin

First Posted Date: 2013-01-30

Last Posted Date: 2020-10-20

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 24

Registration Number: NCT01779687

Locations: 🇳🇱
CRCN Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

ET-blockade and Exercise-induced Vascular Adaptations in T2DM

Phase 4

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Placebo
Drug: Bosentan
Behavioral: Exercise

First Posted Date: 2013-01-30

Last Posted Date: 2016-05-05

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 19

Registration Number: NCT01779609

Locations: 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands

ET-blockade and Exercise Induced Blood Flow in T2DM

Phase 4

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: Placebo
Drug: Bosentan

First Posted Date: 2013-01-30

Last Posted Date: 2016-05-04

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 22

Registration Number: NCT01779596

Locations: 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands

Effects of 'NHGDoc' on Quality of Care

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Other: NHGDoc domain Heart Failure

First Posted Date: 2013-01-23

Last Posted Date: 2018-04-12

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 120

Registration Number: NCT01773057

Locations: 🇳🇱
Radboud University Nijmegen Medical Centre, IQ healthcare, Nijmegen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy